Article

Clinical Study Protocol of the ‘Biomarkers of Severity of COVID-19 Patients’ (BIOMARCOVID) Project

2026-06-17

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> The coronavirus disease 2019 (COVID-19) pandemic has challenged health care systems worldwide, in certain areas exceeding hospital capacities and human resources. This has underscored the importance of having better tools to predict the outcome of potentially severe respiratory infections such as SARS-CoV-2. Predicting COVID-19 severity may allow physicians to better manag...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: baa4ecbd-f583-5b2c-9136-8457735c9667
DOI: 10.64898/2026.06.16.26355763

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical Study Protocol of the ‘Biomarkers of Severity of COVID-19 Patients’ (BIOMARCOVID) ProjectDOI 10.64898/2026.06.16.26355763Read

Studying the pathophysiology of coronavirus disease 2019 – a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)Semantic proximity Read

Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19).Semantic proximity Read

The National COVID Cohort Collaborative: Clinical Characterization and Early Severity PredictionSemantic proximity Read

Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC studySemantic proximity Read

Characterizing COVID-19 Clinical Phenotypes and Associated Comorbidities and Complication ProfilesSemantic proximity Read

Risk Factors and Clinical Phenotypes Associated with Severity in Patients with COVID-19 in Northeast Mexico.Semantic proximity Read

Phenome-wide association of 1809 phenotypes and COVID-19 disease progression in the Veterans Health Administration Million Veteran ProgramSemantic proximity Read

COVID-19: Clinical Assessment, And PrognosisSemantic proximity Read

Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study.Semantic proximity Read

Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19Semantic proximity Read

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypesSemantic proximity Read

A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcomeSemantic proximity Read